Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Veiligheid en effectiviteit van nabiximols voor spasticiteit bij ‘motor-neuron disease’
apr 2019 | Neuro-musculair